Genmab Announces Initiation of Share Buy-Back Program
The share buy-back program will be undertaken on the terms set out below and in accordance with Regulation (EU) No.
- The share buy-back program will be undertaken on the terms set out below and in accordance with Regulation (EU) No.
- The share buy-back program will start on February 15, 2024, and end on March 15, 2024 (unless Genmab terminates or suspends the program).
- Genmab has appointed Danske Bank as lead manager for the share buy-back program.
- Upon initiation of the program, Genmab will issue a weekly announcement in respect of transactions made under the program.